Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00015912
Status:
TERMINATED
Last Update Posted:
2013-01-25
First Post:
2001-05-06
Brief Title:
Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
Keywords: